Sign Up for a Free Account
  • Updated 01.16.2024
  • Released 01.16.2024
  • Expires For CME 01.16.2027

Mesenchymal non-meningothelial tumors [Brief]


Key points

• Mesenchymal non-meningothelial tumors are a diverse group of benign and malignant entities that may affect the central nervous system as primary, secondary, or metastatic lesions.

• Metastatic disease should always be excluded.

• Many are defined by key molecular characteristics.

• They demonstrate a broad range of age at clinical presentation.

• The presenting symptoms are secondary to mass effect on adjacent structures.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125